欢迎来到天天文库
浏览记录
ID:53726127
大小:301.87 KB
页数:4页
时间:2020-04-20
《两种不同化疗方案治疗肺结核合并慢性乙型肝炎患者疗效及对肝功能的影响.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、塞旦肝壁病杂志2014年9月第l7卷第5期JPraeHepmof,Se13.2014.Vo1.17No.5·493··病毒性肝炎·两种不同化疗方案治疗肺结核合并慢性乙型肝炎患者疗效及对肝功能的影响吕玉凤【摘要】目的探讨两种不同化疗方案治疗肺结核合并慢性乙型肝炎患者的疗效及对肝功能的影响。方法选取本院2010年1O月~2012年12月诊治的肺结核合并慢性乙型肝炎患者116例,随机法分为对照组58例,采用2HRZE/4HR及半年化疗疗程,观察组58例患者采用3HESG/9HEG及一年化疗疗程,比较两组患者的治疗效果、肝
2、功能指标改变情况和不良反应发生情况。结果观察组患者总有效率、痰菌转阴率、病灶吸收好转率、空洞缩小率、空洞闭合率分别为98.3%、87.9%、94.8%、93.1%和79.3%,均显著高于对照组患者(87.9%、65.5%、75.9%、72.4%和54.3%);观察组患者AST、ALT、TBIL、ALB、INR、肝功能恢复正常时间分别为(51.7±6.8)U/L、(52.3±7.2)U/L、(26.4±5.7)ixmol/L、(37.8±7.6)g/L、(1.1±0.4)、(16.7±5.8)d,均显著低于对照组患者
3、[(69.3±12.1)U/L、(7O.5士11.3)U/L、(36.5±43)mol/L、(48.54-9.2)g/L、(1.54-0.6)和(28.9±10.3)d];观察组患者肝功能异常发生率、不良反应发生率分别为29.3%和3.4%,显著低于对照组患者(62.1%和15.5%);观察组患者肝功能异常出现时间为(35.7±9.6)d,显著晚于对照组[(17.4±8.2)d,P4、一步验证。【关键词】肺结核;慢性乙型肝炎;4L疗;疗效;药物性肝损伤DOI:10.39696.issn.1672-5069.2014.05.012F_~'ectivenessandimpactonHverfunctionsoftwodiferentchemotherapyregimensintreaO-nentofpatientswithpulmonarytuberculosiscomplicatedbychronichepatitisBLyuYufeng.DepartmentofCommunicableDisea5、se,ChuzhouHospital,Huaian223200,JiangsuProvince,China【Abstract】ObjectiveToinvestigatetheefectivenessandimpactonliverfunctionoftwodifferentchemotherapyregimensintreatmentofpatientswithpulmonarytuberculosiscomplicatedbychronichepatitisB.MethodsOnehundredandsixte6、enpatientswithpulmonarytuberculosisandchronichepatitisBwererecruitedinourhospitalfromOctober2010toDecember2012.Thepatientswerethenrandomlydividedintotwogroups.Patientsincontrolgroup(n=58)weretreatedwith2HRZE/4HRforhalfayear,andpatientsinobservationgroup(n=58)w7、eretreatedwith3HESG/9HEGforoneyear.Theeffectiveness,impactonliverfunctionandadversereactionswererecordedandcomparedbetweenthetwogroups.ResultsTotalefficiency,rateofbacteriologicconversionofsputum,rateoffocusabsorption,rateofcavityshrinkingandrateofcavityclosur8、einpatientsinObservationgroupwere98.3%,87.9%,94.8%,93.1%and79.3%,respectively,significantlyhigherthaninthecontrols(87.9%,65.5%,75.9%,72-4%and54-3%,respectively);AST,ALT,TBIL,ALBand
4、一步验证。【关键词】肺结核;慢性乙型肝炎;4L疗;疗效;药物性肝损伤DOI:10.39696.issn.1672-5069.2014.05.012F_~'ectivenessandimpactonHverfunctionsoftwodiferentchemotherapyregimensintreaO-nentofpatientswithpulmonarytuberculosiscomplicatedbychronichepatitisBLyuYufeng.DepartmentofCommunicableDisea
5、se,ChuzhouHospital,Huaian223200,JiangsuProvince,China【Abstract】ObjectiveToinvestigatetheefectivenessandimpactonliverfunctionoftwodifferentchemotherapyregimensintreatmentofpatientswithpulmonarytuberculosiscomplicatedbychronichepatitisB.MethodsOnehundredandsixte
6、enpatientswithpulmonarytuberculosisandchronichepatitisBwererecruitedinourhospitalfromOctober2010toDecember2012.Thepatientswerethenrandomlydividedintotwogroups.Patientsincontrolgroup(n=58)weretreatedwith2HRZE/4HRforhalfayear,andpatientsinobservationgroup(n=58)w
7、eretreatedwith3HESG/9HEGforoneyear.Theeffectiveness,impactonliverfunctionandadversereactionswererecordedandcomparedbetweenthetwogroups.ResultsTotalefficiency,rateofbacteriologicconversionofsputum,rateoffocusabsorption,rateofcavityshrinkingandrateofcavityclosur
8、einpatientsinObservationgroupwere98.3%,87.9%,94.8%,93.1%and79.3%,respectively,significantlyhigherthaninthecontrols(87.9%,65.5%,75.9%,72-4%and54-3%,respectively);AST,ALT,TBIL,ALBand
此文档下载收益归作者所有